In my third part of my 3 part Q & A with Charles Eggert, CEO of OPX Biotechnologies, he discusses the current state of affairs in the biofuels industry and policy.
ROBERT GLUCK: How do you view the current state of affairs of the American biofuels industry? Biochemicals industry?
In the second part of my Q & A with OPX Biotechnologies' CEO Charles Eggert, he discusses the use of carbon dioxide and hydrogen feedstock, plans for future projects, and converting microbial fuel into jet fuel.
In this first part of my three part interview with OPX Biotechnology’s President and CEO Charles Eggert, he discusses his background, this history and mission of OPX and the company’s efficiency directed genome engineering (EDGE) technology.
ROBERT GLUCK: Please tell our readers a little bit about your background.